Cargando…
The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial
BACKGROUND: Patient-centered care is respectful of and responsive to individual patient preferences, needs, and values. To provide patient-centered care, clinicians need to know and incorporate patients’ context into their communication and care with patients. Patient contextual data (PCD) encompass...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542405/ https://www.ncbi.nlm.nih.gov/pubmed/32965223 http://dx.doi.org/10.2196/20309 |
_version_ | 1783591542774038528 |
---|---|
author | Holt, Jeana M Cusatis, Rachel Winn, Aaron Asan, Onur Spanbauer, Charles Williams, Joni S Flynn, Kathryn E Somai, Melek Laud, Purushottam Crotty, Bradley H |
author_facet | Holt, Jeana M Cusatis, Rachel Winn, Aaron Asan, Onur Spanbauer, Charles Williams, Joni S Flynn, Kathryn E Somai, Melek Laud, Purushottam Crotty, Bradley H |
author_sort | Holt, Jeana M |
collection | PubMed |
description | BACKGROUND: Patient-centered care is respectful of and responsive to individual patient preferences, needs, and values. To provide patient-centered care, clinicians need to know and incorporate patients’ context into their communication and care with patients. Patient contextual data (PCD) encompass social determinants of health and patients’ needs, values, goals, and preferences relevant to their care. PCD can be challenging to collect as a routine component of the time-limited primary care visit. OBJECTIVE: This study aims to determine if patient-provider communication and patient activation are different for patient users and patient nonusers of an electronic health record (EHR)–integrated PCD tool and assess if the impact of using PCD on patient-provider communication and patient activation differs for Black and White patients. METHODS: We describe a randomized controlled trial of a prospective cohort of non-Hispanic White and Black patients who receive primary care services at a midwestern academic health care system in the United States. We will evaluate whether providing PCD through a consumer informatics tool enhances patient-provider communication, as measured by the Communication Assessment Tool, and we will evaluate patient activation, as measured by the Patient Activation Measure for PCD tool users and nonusers. Furthermore, owing to racial disparities in care and communication, we seek to determine if the adoption and use of the tool might narrow the differences between patient groups. RESULTS: The trial was funded in November 2017 and received local ethics review approval in February 2019. The study began recruitment in April 2019 and enrollment concluded in October 2019 with 301 participants. The analysis was completed in May 2020, and trial results are expected to be published in winter 2020. CONCLUSIONS: Recently, there has been increased attention to the role of health information technology tools to enable patients to collaborate with providers through the sharing of PCD. The adoption of such tools may overcome the barriers of current EHRs by directly engaging patients to submit their contextual data. Effectively, these tools would support the EHR in providing a more holistic understanding of the patient. Research further supports that individuals who have robust digital engagement using consumer informatics tools have higher participation in treatment follow-up and self-care across populations. Therefore, it is critical to investigate interventions that elicit and share patients’ social risks and care preferences with the health care team as a mechanism to improve individualized care and reduce the gap in health outcomes. TRIAL REGISTRATION: ClinicalTrials.gov NCT03766841; https://clinicaltrials.gov/ct2/show/NCT03766841 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/20309 |
format | Online Article Text |
id | pubmed-7542405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-75424052020-10-20 The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial Holt, Jeana M Cusatis, Rachel Winn, Aaron Asan, Onur Spanbauer, Charles Williams, Joni S Flynn, Kathryn E Somai, Melek Laud, Purushottam Crotty, Bradley H JMIR Res Protoc Protocol BACKGROUND: Patient-centered care is respectful of and responsive to individual patient preferences, needs, and values. To provide patient-centered care, clinicians need to know and incorporate patients’ context into their communication and care with patients. Patient contextual data (PCD) encompass social determinants of health and patients’ needs, values, goals, and preferences relevant to their care. PCD can be challenging to collect as a routine component of the time-limited primary care visit. OBJECTIVE: This study aims to determine if patient-provider communication and patient activation are different for patient users and patient nonusers of an electronic health record (EHR)–integrated PCD tool and assess if the impact of using PCD on patient-provider communication and patient activation differs for Black and White patients. METHODS: We describe a randomized controlled trial of a prospective cohort of non-Hispanic White and Black patients who receive primary care services at a midwestern academic health care system in the United States. We will evaluate whether providing PCD through a consumer informatics tool enhances patient-provider communication, as measured by the Communication Assessment Tool, and we will evaluate patient activation, as measured by the Patient Activation Measure for PCD tool users and nonusers. Furthermore, owing to racial disparities in care and communication, we seek to determine if the adoption and use of the tool might narrow the differences between patient groups. RESULTS: The trial was funded in November 2017 and received local ethics review approval in February 2019. The study began recruitment in April 2019 and enrollment concluded in October 2019 with 301 participants. The analysis was completed in May 2020, and trial results are expected to be published in winter 2020. CONCLUSIONS: Recently, there has been increased attention to the role of health information technology tools to enable patients to collaborate with providers through the sharing of PCD. The adoption of such tools may overcome the barriers of current EHRs by directly engaging patients to submit their contextual data. Effectively, these tools would support the EHR in providing a more holistic understanding of the patient. Research further supports that individuals who have robust digital engagement using consumer informatics tools have higher participation in treatment follow-up and self-care across populations. Therefore, it is critical to investigate interventions that elicit and share patients’ social risks and care preferences with the health care team as a mechanism to improve individualized care and reduce the gap in health outcomes. TRIAL REGISTRATION: ClinicalTrials.gov NCT03766841; https://clinicaltrials.gov/ct2/show/NCT03766841 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/20309 JMIR Publications 2020-09-23 /pmc/articles/PMC7542405/ /pubmed/32965223 http://dx.doi.org/10.2196/20309 Text en ©Jeana M Holt, Rachel Cusatis, Aaron Winn, Onur Asan, Charles Spanbauer, Joni S Williams, Kathryn E Flynn, Melek Somai, Purushottam Laud, Bradley H Crotty. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 23.09.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included. |
spellingShingle | Protocol Holt, Jeana M Cusatis, Rachel Winn, Aaron Asan, Onur Spanbauer, Charles Williams, Joni S Flynn, Kathryn E Somai, Melek Laud, Purushottam Crotty, Bradley H The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial |
title | The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial |
title_full | The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial |
title_fullStr | The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial |
title_full_unstemmed | The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial |
title_short | The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial |
title_sort | impact of previsit contextual data collection on patient-provider communication and patient activation: study protocol for a randomized controlled trial |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542405/ https://www.ncbi.nlm.nih.gov/pubmed/32965223 http://dx.doi.org/10.2196/20309 |
work_keys_str_mv | AT holtjeanam theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT cusatisrachel theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT winnaaron theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT asanonur theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT spanbauercharles theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT williamsjonis theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT flynnkathryne theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT somaimelek theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT laudpurushottam theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT crottybradleyh theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT holtjeanam impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT cusatisrachel impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT winnaaron impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT asanonur impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT spanbauercharles impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT williamsjonis impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT flynnkathryne impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT somaimelek impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT laudpurushottam impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial AT crottybradleyh impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial |